Tango Therapeutics (TNGX) Retained Earnings (2020 - 2025)
Historic Retained Earnings for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to -$564.4 million.
- Tango Therapeutics' Retained Earnings fell 2166.79% to -$564.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$564.4 million, marking a year-over-year decrease of 2166.79%. This contributed to the annual value of -$501.6 million for FY2024, which is 3509.76% down from last year.
- Per Tango Therapeutics' latest filing, its Retained Earnings stood at -$564.4 million for Q3 2025, which was down 2166.79% from -$580.3 million recorded in Q2 2025.
- Tango Therapeutics' 5-year Retained Earnings high stood at -$362800.0 for Q1 2021, and its period low was -$580.3 million during Q2 2025.
- Over the past 5 years, Tango Therapeutics' median Retained Earnings value was -$318.2 million (recorded in 2023), while the average stood at -$317.5 million.
- Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 26339740.83% in 2021, then tumbled by 2166.79% in 2025.
- Over the past 5 years, Tango Therapeutics' Retained Earnings (Quarter) stood at -$161.3 million in 2021, then crashed by 67.05% to -$269.5 million in 2022, then tumbled by 37.75% to -$371.3 million in 2023, then tumbled by 35.1% to -$501.6 million in 2024, then decreased by 12.53% to -$564.4 million in 2025.
- Its last three reported values are -$564.4 million in Q3 2025, -$580.3 million for Q2 2025, and -$541.4 million during Q1 2025.